Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.

Mediators of inflammation - 1 Jan 2021

Liu Fengjie, Li Lihong, Lan Meng, Zou Tengteng, Kong Zhaodi, Cai Tiange, Wu Xiao Yu, Cai Yu

Abstract excerpt

Breast cancer is one of the top-ranked cancers for incidence and mortality worldwide. The biggest challenges in breast cancer treatment are metastasis and drug resistance, for which work on molecular evaluation, mechanism studies, and screening of therapeutic targets is ongoing. Factors that lead to inflammatory infiltration and immune system suppression in the tumor microenvironment are potential therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Interleukin-1

Share to Molecular Targeted Therapy

Share to Neoplasm Metastasis

Share to Tumor Escape

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34602858
DOI: 10.1155/2021/7785890
PMCID: PMC8486558

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.PMID 34602858Read ↗

Inflammation-associated drug resistance and tumor growth in TNBCSemantic proximity Read ↗

IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy ResistanceSemantic proximity Read ↗

The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs)Semantic proximity Read ↗

Tumor-related interleukins: old validated targets for new anti-cancer drug developmentSemantic proximity Read ↗

Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.Semantic proximity Read ↗

Prognostic Impact of Pro- and Anti-Inflammatory Interleukin mRNA-Expression Signatures in Early Breast CancerSemantic proximity Read ↗

Inflammatory Chemokines as Potential Reversal Agents for Tamoxifen Resistance in Breast Cancer CellsSemantic proximity Read ↗

A novel β-catenin signaling pathway activated by IL-1β leads to the onset of epithelial-mesenchymal transition in breast cancer cells.Semantic proximity Read ↗

Association Between Depression and Breast Cancer: TNF/TNFRSF1β and LEP/LEPR AxisSemantic proximity Read ↗

How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?Semantic proximity Read ↗

The role of the insulin-like growth factor-1 system in breast cancerSemantic proximity Read ↗

Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.